EDQM 发布 CEP 姐妹文件申请指南修订版 PA PH CEP (09) 141
EDQM Updates Guidance on CEP Sister File Applications
EDQM 发布了姐妹文件申请指南修订版 PA PH CEP (09) 141,该文件已于 2026 年 9 月 1 日生效。修订澄清了受理资格条件,涉及不同中间体、不同起始物料或不同试剂时原则上不适用,但申请人若能证明基本化学原理与反应机理与作为参照的 CEP 档案一致,仍可被考虑。
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published a revised version of its guidance on applications for "sister files": PA PH CEP (09) 141. The original guidance document provided the initial framework for the sister file procedure. It set out the basic principles for submitting and assessing related CEP applications and helped applicants and assessors determine when the procedure could be used.The update reflects the EDQM's experience with the sister file procedure over many years. Its purpose is to improve the consistent interpretation and application of the procedure, while providing applicants with greater clarity on eligibility, documentation and assessment expectations.The revised guidance is intended to support: a consistent understanding of the sister file procedure; the correct classification and evaluation of Certificate of Suitability (CEP) applications; greater transparency in the assessment process; and equal treatment of applicants.Clarification of eligibility criteriaOne of the most important changes concerns the conditions under which a sister file application may be accepted. In principle, an application may not qualify as a sister file if the proposed manufacturing process involves: different intermediates; different starting materials; different reagents.However, such an application may still be considered if the applicant can demonstrate that the fundamental chemical principles and reaction mechanisms remain the same as those described in the CEP dossier used as the reference.This clarification is intended to help applicants assess at an early stage whether the sister file route is appropriate and to ensure that applications are classified consistently.Extension to sterile substancesThe scope of the sister file procedure has also been broadened. Under the revised guidance, CEP applications for sterile substances may now fall within the scope of the procedure. Applications for TSE CEPs, however, remain excluded.Additional examples and documentation requirementsThe revised document includes a wider range of examples describing situations that may be considered acceptable under the sister file procedure. These examples are intended to illustrate how the eligibility criteria should be applied in practice.In addition, the EDQM has provided further clarification regarding the documentation that applicants are expected to submit in support of a sister file application. This should help applicants prepare more complete submissions and reduce uncertainty during the classification and assessment process.The revised guidance, PA PH CEP (09) 141, entered into force on 1 September 2026. Applicants planning to use the sister file procedure should review the updated guidance carefully, particularly the revised eligibility criteria and the clarified documentation expectations.
来源:ECA GMP News · gmp-compliance.org